AtriCure (NASDAQ: ATRC) reported Q2 EPS of ($0.01), $0.22 better than the analyst estimate of ($0.23). Revenue for the quarter came in at $51.8 million versus the consensus estimate of $49.9 million.

GUIDANCE:

AtriCure sees FY2018 revenue of $193-197 million, versus the consensus of $195 million.

For earnings history and earnings-related data on AtriCure (ATRC) click here.